J Nucl Med 1999 Apr;40(4):591-603
Oncological applications of FDG PET imaging: brain tumors, colorectal
cancer, lymphoma and melanoma.
Delbeke D
This article will focus primarily on body oncology diagnosis, staging and therapy
monitoring using fluorodeoxyglucose (FDG) PET imaging. Common pitfalls and artifacts in
body FDG imaging will be covered. Examples of diagnosis, staging and therapy monitoring of
brain tumor, colorectal cancer, lymphoma and melanoma will be given. Importance of
correlation with anatomic imaging and practical use of FDG imaging in patient management
will be stressed.
PMID: 10210218, UI: 99224924
